The question of payment to egg donors has recently focused the attention of both the Human Fertilisation and Embryology Authority (HFEA) and licensed clinics. An acute shortage of egg donors and the rising costs of assisted conception treatment are matters of grave concern to many patients. To understand the emotional and social effects of egg sharing and egg donation, we conducted a survey of attitudes in a group of women who had some knowledge or experience of egg donation. A total of 750 questionnaires were sent out of which 217 were returned within the specified time limit. From these, 107 respondents had experience of egg donation and 110 had made enquiries about donation. The data from these questionnaires were collated and tabulated by the National Opinion Polls (NOP) Research Group. An analysis of the data produced the following key findings: (i) donating or sharing eggs is a social issue, 94% discuss it with partners/family/friends; (ii) altruistic motives are not the prerogative of non-patient volunteers-egg share donors felt that helping the childless was as important as having a chance of in-vitro fertilization (IVF) for themselves; (iii) the treatment procedure causes the most anxiety for egg donors. The recipients were most concerned about delays, donor characteristics and how the eggs were allocated; (iv) most respondents (65%) with prior experience of egg sharing would do it again -63% of egg share donors, 72% of egg share recipients; (v) cash rewards to egg donors and outright advertising for donors were rejected by 64 and 62% of the sample respectively; and (vi) counselling was highly valued and there were no instances of 'shattered lives' after treatment. The findings do not support the recently announced intentions of the HFEA to disallow payment to gamete donors on the grounds of devalued consent. There is no precedent in modern medicine for egg sharing. The patients surveyed drew a clear distinction between egg sharing and financial rewards. As long as egg donation is not covered by the National Health Service, it is fairer to offer egg sharing than to refuse treatment to those unable to pay.
Introduction
The growing and unmet demand for egg donation has been the subject of considerable discussion worldwide. Different systems of health care allow different forms of anonymous egg donation which in general fall into one of the following four categories: (i) altruistic-anonymous donors are non-patient volunteers who would undergo egg collection for the benefit of someone unknown to them; (ii) commercial-anonymous are those women who would accept money in return for donating eggs; (iii) known-anonymous egg donation is a scheme whereby the matched donor and recipient remain anonymous to each other but the identity of the donor is known to an unmatched recipient; and (iv) the infertileanonymous are those patients who would volunteer to donate a proportion of their eggs in return for subsidized in-vitro fertilization (IVF) treatment (shared egg donation). The merits of the different schemes have been discussed previously Englert, 1996; Lockwood, 1997) .
The key advantage of shared egg donation is that no third party takes risks for the benefit of the recipient because the donor requires drugs and an operation for her own needs. Further it provides treatment for those who cannot obtain IVF within the UK health care system and who must otherwise fund it privately. Finally, it also provides an opportunity to express altruism in a pragmatic way between an anonymous donor and matched recipient. The safeguards to govern the above schemes have been described previously Simons et al., 1996) .
However, some objections to egg sharing have also been raised. The main objection concerns the quality of consent given by the donor. Are patients only giving their consent to share eggs in order to obtain much desired treatment? Secondly, it has been suggested that some children born from treatment may suffer later in life knowing their parents paid a donor to contribute, to their conception although the basis for this argument is unclear. Thirdly, subsidized fertility treatment for egg donors could be seen as contrary to a cultural preference for voluntary unpaid donation, such as blood and tissue donation. When declaring its opposition to any financial compensation for gamete donors (currently £15 per act of donation), the Human Fertilisation and Embryology Authority (HFEA) subsequently equated egg sharing with payment in cash for gamete donors (Johnson, 1997) .
To date, the major difficulty about claims and counter claims regarding the advantages and disadvantages of egg sharing is that there is virtually no information available about the feelings and opinions of donors or recipients in egg share programmes. The success of any new treatment procedure depends largely on how it is perceived by patients. If they agree with the concerns mentioned above then the HFEA's concerns are valid. If not, then in the absence of contrary social or medical reasons, egg sharing should be seen as a pragmatic approach to alleviate the shortage of egg donors. This is the view in Israel and Denmark where egg sharing is the only form of egg donation allowed by law. It is also supported by a growing number of British experts and commentators (Lockwood, 1997; Ridley, 1997) .
In this paper we report the results of a comprehensive survey which addressed the emotional and practical benefits as well as problems of donation and egg sharing for the patients involved. The views of enquirers are also documented. It is hoped that the results will contribute to the development of balanced policies on donor recruitment.
Materials and methods
A senior fertility counsellor and long-term member of the Market Research Society (B.M.) was responsible for designing and analysing this study in collaboration with others (K.K.A. and E.G.S.). A selfcompletion questionnaire was designed to address five key areas which affect egg donors namely: source of awareness, motivation to participate, reactions to the medical procedures, attitudes on egg donation issues, and finally, the perceived effects of treatment.
Participants were obtained through appeals in patient support group magazines (Child and Issue) requesting participation of experienced donors and recipients, as well as those interested in donating or receiving eggs (enquirers). Anyone interested was asked to call in for a questionnaire. Experienced egg donors and enquirers registered with our own centres were also sent a questionnaire.
Concurrent publications in the media about egg share successes also resulted in many requests to participate. As a result a total of 750 women were sent a questionnaire and prepaid return envelope between May 16 and June 17, 1996. Thus, the survey described here preceded by one month the announcement (July 22) by the HFEA of its decision to phase out payments to gamete donors.
A total of 234 (31%) of the questionnaires were returned. This is considered to be a good response rate for a lengthy questionnaire. The average response rate for a postal questionnaire is 20% according to National Opinion Polls (NOP). Those who failed to reply were not sent reminders. Responding to questionnaires, whether conducted on the doorstep, the street, the telephone or by post is the choice of the respondent according to the Market Research Society Code of Practice. The majority of questions were accompanied by space for comments, which were encouraged. Comments provided many quotations, some of which feature in this report.
Questionnaires were individually analysed and coded and then sent to the NOP for collation, tabulation and formulation into tables: 553 in total. The χ 2 test was used to determine the statistical significance of differences between sub-groups. The responses to all of the questions were statistically tested to see whether: experienced versus enquirers; recipients versus donors; egg sharers versus anonymous/ known donors, or egg share versus anonymous known recipients responded significantly differently.
Results
The total sample reported in this analysis was 217 (28.9% of the total) and not 234, as 17 questionnaires were returned after the agreed date for submission of the data to NOP. However, 2846 the views expressed in the late questionnaires were in accord with the majority view.
The majority of participants were middle class, married, Caucasian women who had benefited from tertiary education (Table I ). There was an equal representation of experienced donors and recipients (n ϭ 107) and those who were enquiring about donating or receiving (n ϭ 110). As might be expected, the majority were aged 25-44 years.
Non-patient volunteer donors were no more middle class (63%, n ϭ 12) than egg share donors (47%, n ϭ 49). The difference was not statistically significant (P Ͻ 0.1) Concerns that middle class recipients may be exploiting working class 'poorer' donors, especially in egg share schemes, are not borne out by this study. Nor would it be possible to conclude that donors, especially egg share donors, could be coerced into donating when 50% of experienced donors (n ϭ 61; 49 egg share and 12 non-patient volunteer donors) had the benefit of tertiary education. Amongst all experienced recipients, 58% (n ϭ 46) had a tertiary education.
Features in the media create awareness of egg donation for a ABC1 ϭ professional and white collar workers; C2D ϭ skilled and unskilled blue collar workers. most donors and recipients (65%, n ϭ 217; Table II ). This includes information from family and friends and colleagues who were also informed via the media. This is not dissimilar to previously reported studies (Power et al., 1990) . Respondents in our study who were made aware of egg donation by their consultants and general practitioners (GPs) were significantly more likely to be experienced patients who had been involved in egg donation 2 years or more previously (P Ͻ 0.01). Like adoption, donating or receiving eggs is a social issue. Virtually all the respondents (94%) in the study indicated that they discussed it with their partner, family and friends. Only 3% subsequently discussed egg sharing with their GP prior to initiating treatment, a phenomenon other researchers have also found (Billett et al., 1996) . Positive feed-back from prospective fathers and close relations appears essential for participation. Negative feed-back created doubts and anxiety, and those who received it were unlikely to proceed.
Altruism is not the prerogative of non-patient volunteer donors; 86% of egg share donors and 79% of egg share donor enquirers felt that giving hope to the childless was a significant motive for participation: 'Helping us have a child', was a common statement by 75% of egg share donors and 62% of egg share enquirers respectively (Table III) .
All respondents (experienced and enquirers) were asked to describe their main concerns about treatment and the best and worst features of egg sharing or donation as they might explain it to a friend. The main concern expressed (n ϭ 217) was about the IVF procedure and side-effects (81%). Failure (32%), how eggs are shared (32%), concern for the child (26%) and not knowing the recipients outcome (18%), were additional concerns (N.B. adds to Ͼ100% due to multiple answers).
Experienced donor and recipient patients (n ϭ 107) were significantly more likely to be concerned about failure than enquirers (P Ͻ 0.001) and 63% of experienced donors (n ϭ 61) were disappointed that they would never know whether or not the recipient became pregnant: 'It's like giving a gift that is never acknowledged'. Other researchers have found similar reactions amongst donors (Söderström-Anttila, 1995; Cook et al., 1995; Lui et al., 1995) .
The worst aspects of treatment for experienced donors and recipients (n ϭ 107) were physical: the drugs, the egg retrieval and side-effects were a negative feature for 64% of the experienced respondents (n ϭ 107; Table IV ). Concerns about the donor were also expressed by 67% of experienced recipients (n ϭ 46), particularly details of donor screening and matching.
The resulting child was a source of concern. Many (50% of 2847 recipients) were worried about telling the child of its origins; whereas 31% of donors were also aware of longer term implications such as: 'Could they meet and marry?'. For 25% of experienced donors (n ϭ 61) stress was also created by a seeming lack of care and concern in the clinic they attended: 'being treated as a number', 'brusque nurses', 'no time for questions,' were typical complaints. In the attitude scale questions, respondents overwhelmingly indicated that counselling was an important part of the egg donation/egg sharing procedure (Figure 1a) . In contrast only one-third of respondents felt they wanted to discuss egg donation with their GP (Figure 1b) . The vast majority (85%) of the experienced patients (n ϭ 107) felt they had been given enough time to think about and talk through the issues of egg donation at the clinic.
A requirement of the HFEA licence issued for egg donation is that all patients must be properly briefed before consenting to treatment. Potential donors and recipients applying to our programme receive a booklet describing the procedure before they see the consultant who will then describe the procedure in more detail including potential risks and side-effects, as well as success rates. Egg share (or donation) participants will see the counsellor to ensure that they are fully aware of all the issues and are confidently giving their informed consent. Of 100 women who come forward as egg share donors to the Cromwell IVF and Fertility Centres only 20% will complete treatment. Medical, social or psychological problems will prevent participation for many (Ahuja, 1997) .
Clearly, time to talk about relevant issues with the counsellor and ask questions of consultants, without being rushed through treatment is important to all participants. Most respondents (80%) felt that donors have the advantage of feeling satisfaction and the pride of 'giving in their lifetime' (Figure 1c) . Twice as many agreed that a child has a right to know its origins (46%), as disagreed (23%) (Figure 1d ). The majority of all respondents (62%) rejected advertising for donors. The main reasons for rejection for recipients was the desire for anonymity and a preference for the clinics and professions to arrange donations and do the matching (Figure 2a) . Some of the experienced donors (34%, n ϭ 61) felt they might respond to advertisements because they sympathized with the desperation of the recipient.
A significant minority of the respondents in this study (36%) wanted to see payment to donors allowed. They felt it might encourage more donors to come forward, 'especially the younger, more fertile donors' (Figure 2b ). Asked how much should be paid, responses ranged from £10 to £50 per ovum to as high as £2000 per procedure. The majority (64%) who rejected cash payments felt it would encourage the wrong people for the wrong reasons, or they were repelled about putting a price on a baby. There was virtually no support for the idea that the clinics should charge the recipient and the donor two full fees for providing independent treatments. However, a significant (Figure 2c ). The majority of respondents (55%), strongly disapproved of this practice citing 'taking advantage of my misfortune' and 'it creates double stress for recipients' as their main reasons. Despite the concerns expressed by experienced respondents before going through a cycle, as well as their worst experiences during treatment, the majority (63%, n ϭ 107) felt that the treatment had been better than expected. Being well cared for, treated with respect, with time for questions and counselling were compensation even for those who experienced some sideeffects. Therefore, 65% felt motivated to go through another treatment cycle (Table V) . Schover et al. (1991) also found a high percentage of donors willing to donate again. The recipients were the most positive about another cycle (72%, n ϭ 46) because the first cycle had been 'encouraging' and made them 'hopeful'. Egg share donors (63%, n ϭ 49) were also positive: 'it brought out the altruist in me', 'I would hope someone would be there if I needed eggs' reflects the enthusiasm of many.
Only one third of non-patient volunteer donors would consider doing it again as the procedure involved 'too much emotional upheaval, disrupting life, work and family'. Lockwood (1997) and Saunders and Garner (1996) have also pointed out that there are many emotional pitfalls in known donation such as coercion, feelings of obligation and guilt, families falling out and even manipulation, e.g. donating to pay a debt, all of these contribute to a low rate of repeat treatment offers from volunteer donors.
The most negative feelings expressed immediately after treatment were from recipients and non-patient volunteer donors (Table VI) . Recipients were significantly more negative than donors immediately after treatment (P Ͻ 0.005). When asked to focus on longer term effects, feelings were noticeably more positive amongst recipients as well as donors. The one exception was donors with long-term side-effects, representing 7% of all donors. While this 7% is unfortunate, the findings clearly indicate that participation in egg sharing or egg donation does not result in 'shattered lives'.
Discussion
An interesting positive profile of egg share donors emerges from this survey. They are not the put-upon poor, but a welleducated middle class group of self determined women who are capable of addressing the issues. They initiate contacts with infertility clinics and use the counselling sessions to explore various issues. They make a distinction between cash incentives which they reject, and the treatment benefits, which they respect and need. They ensure family support and then make a commitment to give hope to the childless, as well as to themselves. They do not appear to suffer post-treatment problems and, if required, 63% would share eggs again. This is hardly the profile of women who could easily be induced into consenting to a treatment procedure that would jeopardize their own chances of a family, and scar them psychologically, just to obtain partial funding. The purpose of the research was to gain an insight into the feelings and opinions of donors and recipients who have experienced egg sharing or egg donation as well as those who are considering doing so. The findings will be discussed in the light of the three reservations about egg sharing which have been recently raised by the HFEA.
Firstly, donors will feel coerced into donating to gain a financial advantage. This research has shown that 86% of egg share donors and 79% of egg share enquirers were motivated to participate in order to help others, as well as wanting to help themselves (75% donors, 62% enquirers). The majority (58%) had the benefit of tertiary education (including 51% of all egg share donors). Nearly half (49%) of the egg share donors were middle class making it difficult to conclude that these donor women, aged 30-35 years, were socially vulnerable and easy to persuade. Nor is it conceivable that in a highly regulated system, such as exists in the UK any licenced clinic would disregard the rigid code of practice.
Egg share donors feel negative about both cash incentives and targeted advertising for donors. This contrasts sharply with their view of egg sharing which they regard as altruistic and helpful to both participants. Further, donors, especially egg share donors, had more positive reactions about the treatment procedures, in particular the support they received during treatment. As a result 63% of egg share donors were hoping to donate again. Egg share donors also had more positive post treatment feelings including a desire to encourage others to consider donation.
The second reservation expressed by the HFEA is that children born to recipients might suffer later in life knowing their parents had paid a donor. (Johnson, 1997) . To date there has been no evidence or support for this speculative suggestion. The majority of would-be parents already pay large sums of 2850 money to undergo IVF as there is little treatment available through the National Health Service (NHS). Indeed most NHS centres in the UK are profit-oriented because they encourage full fee paying private patients into the system. According to the College of Health, nearly 80% of all treatment cycles in this country are privately funded, a situation which has not changed significantly since the early, 1980s. In addition, those who wish to adopt from abroad, because they feel unable to take on the care of older more difficult children available for adoption in the UK, are required to pay local authorities £2000-£3500 just to conduct their Home Study (Bennett and Mostyn, 1991; Baines, 1993) . Furthermore, a typical surrogacy arrangement will cost, in expenses alone in excess of £10 000 in the UK. If paying to become a parent is deemed inappropriate it would seem sensible to stop all forms of payment to create families.
Most children resulting from donor insemination (DI) are never told of their origins despite initial intentions to do so (Amuzu et al., 1990; Cook et al., 1995) . For decades UK patients have obtained DI on a self funding basis with no recorded ill effects on the children or the family. Indeed, Golombok et al. (1995) have shown that children born following DI and IVF, as well as adopted children, are happier, better adjusted and spend more time with their parents than natural children. Money has been seen as an acceptable form of exchange for infertility treatment by the HFEA, until it is applied to egg donation or egg sharing, when it becomes unacceptable. It is also curious that a regulatory body that is itself partly funded by a licence fee from those receiving IVF treatment should choose to attach such a rigid moral stance with respect to money.
The third objection of the HFEA was that compensation for egg donors, either monetary or in the form of infertility treatment, is seen as wrong because other more established forms of donation such as organs and blood are conducted without compensation. It is suggested that there is a cultural preference in the UK for unrewarded donation and that compensating donors diminishes their altruism (Johnson, 1997) . One of the most important findings of our survey was the emergence of a clear distinction between cash payments and the so-called 'treatment in kind' medical procedures such as egg sharing. The majority (64%) of respondents objected to cash rewards for egg donation which is consistent with the requirements of the 1990 Human Fertilisation and Embryology Act. However, a similar proportion of experienced egg share donors and recipients (65%, n ϭ 107; Table IV) supported egg sharing. This contrasts sharply with the proposed HFEA view that, for egg donors, cash rewards and subsidized IVF treatments are equivalent.
Widespread opposition in the profession has been registered in the UK against the HFEA policy and this is based upon practical concerns about the likely reduction and escalating costs of sperm donations for fertility treatment (Cooke, 1996; British Fertility Society, unpublished; British Andrology Society, unpublished; Dawson, 1997; Ridley, 1997) . This is supported further by recent pilot studies which have failed to recruit sperm donors without compensation (Cooke, 1996; McLaughlin et al., 1997) . The present study also questions the validity of the stance taken by the HFEA who regard cash rewards and subsidized fertility treatment as ethically the same. Respondents drew a clear distinction between self interest and benefits on the one hand, and disinterested cash payments on the other; egg sharing created a logical link between self interest and the common good for most respondents.
Since the advent of egg sharing more donors have become available. Egg sharing enables 'altruistic reciprocity' between two couples in need of unobtainable IVF. In modern society, just as in the entire biological kingdom altruism is never diminished by reciprocal needs (Trivers, 1971; Mount, 1996; Ridley, 1997) . Indeed, appeals for reciprocity are often used to recruit organ and blood donors. In his famous survey of blood donors, Titmuss (1973) found that mutual aid was a main motivation for participants. Responding to the slogan 'the life you save may be your own' does not diminish the gift of blood donation.
Egg sharing, also, does not diminish the feeling of mutual well-being between egg share donors and anonymous recipients regardless of treatment outcome. Egg share donors were more positive about themselves after treatment than the non-patient volunteer donors who were the most likely to complain of side-effects. Attempts to make egg sharing fit into the stereotyped mould of 'volunteer' blood and organ donation (Shenfield and Steele, 1995; Johnson, 1997) ignores the many factors which make egg donation unique. Indeed, as long as egg donation is not covered by the NHS, it is fairer to offer egg sharing than to refuse treatment to those unable to pay.
In fact, it is our view that there is no precedent in modern medicine for egg sharing. Whilst all donors of any tissue are to some extent giving for altruistic reasons, the basis of giving for each type of tissue differs significantly. In most circumstances, organ donors are dead before their organs are removed. Blood donors are inconvenienced for an hour or so and have to complete a simple procedure which is virtually risk free. In contrast egg sharers and donors face challenges of numerous visits to the clinic, accept possible unknown sideeffects from ovulation inducing drugs and then undertake an operation to retrieve eggs. All of these were considered by egg donors to be the worst aspects of treatment.
Large sums of money are budgeted for publicity directed 2851 towards potential blood and organ donors. This is unlikely to be forthcoming for egg donation because the procedure is unlikely to attain sufficient priority in the NHS. It would be a gross distortion of the facts to presume that there is a preferred national culture of unrewarded giving which becomes dogma and embraces all forms of tissue donation in the UK, regardless of the risks involved. Parliament would hardly base a key policy on an unbalanced view of the medico-social evidence which has emerged since the passage of the Human Fertilisation and Embryology Act of, 1990. Nor would the media remain a disinterested onlooker when the proposed policies lead to patient anguish, due to the short supply of gametes. Even if sufficient non-patient volunteers could be recruited there is increasing unease about medical aspects of their treatment which cannot be ignored. There are reports of an association between ovarian stimulation and cancer (Banderra et al., 1995; Dor et al., 1996; Shusan et al., 1996; Ahuja and Simons, 1998) . These have quite different implications for a patient who requires IVF in order to have a child and opts to take the risks associated with ovarian stimulation compared to a known or anonymous donor who is likely already to be a mother of young children (Ramogida, 1997) . Would she be willing to take the risk once she understood the issues unless there was undue family or peer pressures? Sister donors have shown a decreased ovarian response to stimulation even when large doses of drugs are used (Sung et al., 1997) . There is also evidence of a high incidence of family turmoil and reproductive traumas amongst non-patient volunteers, including child abuse. Also, know donor situations can be an emotional minefield of manipulation and abuse, e.g. donation to pay a debt (Schover et al., 1991; Saunders and Garner, 1996; Lockwood, 1997) . These findings should not be ignored. It would indeed be ironic if a patient who is menopausal following cancer treatment is obliged to call on a sister to donate only to subject the donor to a possible cancer risk (Simons and Ahuja, 1998) .
By all accounts implementation of the HFEA proposals would result in a marked reduction in egg donation in general and potentially expose egg donors to risks which are as yet unclear. We doubt very much whether that would have been the intention of the 1990 Act.
